Article
Initiation of Medications for AUD Prior to Discharge Leads to Lower Rates of Return to Hospital
December 2, 2024
linical question: How does the initiation of medications for alcohol use disorder (AUD) at discharge affect 30-day post-discharge outcomes? Background: AUD is highly prevalent (affecting...
Article
Opioid Prescribing and Outcomes in Patients with SCD Post-2016 CDC Guideline
November 1, 2024
Dr. Klubnick Clinical question: Did the 2016 U.S. Centers for Disease Control and Prevention (CDC) guideline for prescribing opioids for chronic pain change opioid prescribing practices and...
Article
“First You Take a Drink, Then the Drink Takes a Drink, Then the Drink Takes You”
October 1, 2024
Substance use disorders in physicians The title of this article, a quote by F. Scott Fitzgerald, illustrates the experience of alcohol use disorder. Although physicians are comfortable recognizing...
Article
Opioid Use Disorders in Adolescents
July 1, 2024
Dr. Trope, a pediatric hospitalist at Santa Clara Valley Medical Center in San Jose, Calif., and an affiliated clinical instructor at the Lucille Packard Children’s Hospital at Stanford University...
Article
Inpatient Management of Patients with Opioid Use Disorder
July 1, 2024
This session was a high-yield overview of the management of hospitalized patients with opioid use disorder (OUD) presented by Dr. South, an addiction medicine physician who treats patients with...
Article
Opioids Confer Risk without Improved Pain Control
March 1, 2024
Clinical question: How effective and safe are opioids for the treatment of acute, non-specific low back and neck pain? Background: Despite the lack of evidence of the effectiveness of opioids for...
Article
Bridging the Gap: How Do You Interpret an Osmolal Gap?
November 1, 2023
Case A 53-year-old man with chronic kidney disease on hemodialysis presented with abdominal pain, nausea, and vomiting. He drinks three to 12 beers daily and denied ingestion of toxic alcohol. Labs...
Article
A High Yield Review of Cannabinoid Hyperemesis Syndrome
November 1, 2023
Dr. Berry Presenters: Rebecca M. Cantu, MD, MPH, Brittany M. Slagle, DO, and Sara Sanders, MD The overall prevalence of cannabinoid hyperemesis syndrome (CHS) is 0.1% and is more common in young...
Article
Crystal, Cake, and K2: What Teens are Smoking, Snorting, Shooting, and Swallowing
November 1, 2023
Dr. Owerko Presenters: Paul Scalici, MD, Meghan Hofto, MD, MPH, DTMH, Lauren Nassetta, MD, James Gambrell, MD During this PHM 2023 session, four pediatric hospitalists tackled a broad topic that...
Article
Emerging Threat: Illicit Drugs Adulterated with Xylazine
September 1, 2023
Xylazine is a semi-synthetic, non-opioid, sedative paralytic used in veterinary medicine as a tranquilizer. It’s an alpha agonist, similar in chemical structure to clonidine and dexmetomidine.1 It...